Home Access taking phone orders nationwide for home HIV test service; J&J accelerates Confide roll-out.
This article was originally published in The Gray Sheet
Executive Summary
HOME ACCESS TAKING PHONE ORDERS FOR HOME HIV TEST SERVICE NATIONWIDE following FDA approval July 22 for a premarket approval application for the product. Shipments of the Home Access Express system will commence Aug. 1, the company says, followed by a roll-out of the standard Home Access system "in the next few weeks." Hoffman Estates, Illinois-based Home Access Health submitted a PMA for the over-the-counter HIV testing service in May 1995. The controlled release approach will allow the firm time to assess demand for its product and reduce the potential of an order backlog.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.